Literature DB >> 15891640

Glutathione S-transferase gene polymorphisms in presbycusis.

Nurcan Aras Ateş1, Murat Unal, Lülüfer Tamer, Ebru Derici, Sevim Karakaş, Bahadir Ercan, Yavuz Selim Pata, Yücel Akbaş, Yusuf Vayisoğlu, Handan Camdeviren.   

Abstract

HYPOTHESIS: Glutathione and glutathione-related antioxidant enzymes are involved in the metabolism and detoxification of cytotoxic and carcinogenic compounds as well as reactive oxygen species. Reactive oxygen species generation occurs in prolonged relative hypoperfusion conditions such as in aging. The etiology of presbycusis is much less certain; however, a complex genetic cause is most likely. The effect of aging shows a wide interindividual range; we aimed to investigate whether profiles of (glutathione S-transferase (GST) M1, T1 and P1 genotypes may be associated with the risk of age-related hearing loss. PATIENTS AND METHODS: We examined 68 adults with presbycusis and 69 healthy controls. DNA was extracted from whole blood, and the GSTM1, GSTT1 and GSTP1 polymorphisms were determined using a real-time polymerase chain reaction and fluorescence resonance energy transfer with a Light-Cycler Instrument. Associations between specific genotypes and the development of presbycusis were examined by use of logistic regression analyses to calculate odds ratios and 95% confidence intervals.
RESULTS: Gene polymorphisms at GSTM1, GSTT1, and GSTP1 in subjects with presbycusis were not significantly different than in the controls (p > 0.05). Also, the combinations of different GSTM1, GSTT1, and GSTP1 genotypes were not an increased risk of presbycusis (p > 0.05).
CONCLUSION: We could not demonstrate any significant association between the GSTM1, GSTT1, and GSTP1 polymorphism and age-related hearing loss in this population. This may be because of our sample size, and further studies need to investigate the exact role of GST gene polymorphisms in the etiopathogenesis of the presbycusis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891640     DOI: 10.1097/01.mao.0000169774.23668.f1

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  17 in total

1.  Antioxidant enzymes, presbycusis, and ethnic variability.

Authors:  Anthony Bared; Xiaomei Ouyang; Simon Angeli; Li Lin Du; Kimberly Hoang; Denise Yan; Xue Zhong Liu
Journal:  Otolaryngol Head Neck Surg       Date:  2010-08       Impact factor: 3.497

2.  Ultrarare heterozygous pathogenic variants of genes causing dominant forms of early-onset deafness underlie severe presbycusis.

Authors:  Sophie Boucher; Fabienne Wong Jun Tai; Sedigheh Delmaghani; Andrea Lelli; Amrit Singh-Estivalet; Typhaine Dupont; Magali Niasme-Grare; Vincent Michel; Nicolas Wolff; Amel Bahloul; Yosra Bouyacoub; Didier Bouccara; Bernard Fraysse; Olivier Deguine; Lionel Collet; Hung Thai-Van; Eugen Ionescu; Jean-Louis Kemeny; Fabrice Giraudet; Jean-Pierre Lavieille; Arnaud Devèze; Anne-Laure Roudevitch-Pujol; Christophe Vincent; Christian Renard; Valérie Franco-Vidal; Claire Thibult-Apt; Vincent Darrouzet; Eric Bizaguet; Arnaud Coez; Hugues Aschard; Nicolas Michalski; Gaëlle M Lefevre; Anne Aubois; Paul Avan; Crystel Bonnet; Christine Petit
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

Review 3.  Role of antioxidants in prevention of age-related hearing loss: a review of literature.

Authors:  Elham Tavanai; Ghassem Mohammadkhani
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-17       Impact factor: 2.503

Review 4.  Recent advances in the study of age-related hearing loss: a mini-review.

Authors:  Ambrose R Kidd Iii; Jianxin Bao
Journal:  Gerontology       Date:  2012-06-15       Impact factor: 5.140

5.  GRM7 variants confer susceptibility to age-related hearing impairment.

Authors:  Rick A Friedman; Lut Van Laer; Matthew J Huentelman; Sonal S Sheth; Els Van Eyken; Jason J Corneveaux; Waibhav D Tembe; Rebecca F Halperin; Ashley Q Thorburn; Sofie Thys; Sarah Bonneux; Erik Fransen; Jeroen Huyghe; Ilmari Pyykkö; Cor W R J Cremers; Hannie Kremer; Ingeborg Dhooge; Dafydd Stephens; Eva Orzan; Markus Pfister; Michael Bille; Agnete Parving; Martti Sorri; Paul H Van de Heyning; Linna Makmura; Jeffrey D Ohmen; Frederick H Linthicum; Jose N Fayad; John V Pearson; David W Craig; Dietrich A Stephan; Guy Van Camp
Journal:  Hum Mol Genet       Date:  2008-12-01       Impact factor: 6.150

6.  CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population.

Authors:  Ertan Altayli; Sezgin Gunes; Ali Faik Yilmaz; Serdar Goktas; Yuksel Bek
Journal:  Int Urol Nephrol       Date:  2008-08-09       Impact factor: 2.370

7.  Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment.

Authors:  E Van Eyken; G Van Camp; E Fransen; V Topsakal; J J Hendrickx; K Demeester; P Van de Heyning; E Mäki-Torkko; S Hannula; M Sorri; M Jensen; A Parving; M Bille; M Baur; M Pfister; A Bonaconsa; M Mazzoli; E Orzan; A Espeso; D Stephens; K Verbruggen; J Huyghe; I Dhooge; P Huygen; H Kremer; C W R J Cremers; S Kunst; M Manninen; I Pyykkö; A Lacava; M Steffens; T F Wienker; L Van Laer
Journal:  J Med Genet       Date:  2007-05-18       Impact factor: 6.318

8.  Age-Related Hearing Impairment Associated NAT2, GRM7, GRHL2 Susceptibility Gene Polymorphisms and Haplotypes in Roma and Hungarian Populations.

Authors:  Petra Matyas; Etelka Postyeni; Katalin Komlosi; Renata Szalai; Judit Bene; Lili Magyari; Bela Melegh; Kinga Hadzsiev
Journal:  Pathol Oncol Res       Date:  2018-02-17       Impact factor: 3.201

9.  Protective Effects of Silymarin Against Age-Related Hearing Loss in an Aging Rat Model.

Authors:  Elham Tavanai; Ghassem Mohammadkhani; Saeid Farahani; Shohreh Jalaie
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-03-14

10.  Tuberous sclerosis complex-mediated mTORC1 overactivation promotes age-related hearing loss.

Authors:  Xiaolong Fu; Xiaoyang Sun; Linqing Zhang; Yecheng Jin; Renjie Chai; Lili Yang; Aizhen Zhang; Xiangguo Liu; Xiaochun Bai; Jianfeng Li; Haibo Wang; Jiangang Gao
Journal:  J Clin Invest       Date:  2018-09-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.